/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Orthologic Corp.\n \n\n\n\n\n
Nov 20 11:44 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 17, 2009 3:48 PM EST
\n\n \n Capstone Therapeutics Announces Transfer to Nasdaq Capital Market - GlobeNewswire\n \n \n
\n\n Nov 09, 2009 8:02 AM EST
\n\n \n Capstone Therapeutics Announces Third Quarter 2009 Financial Results - GlobeNewswire\n \n \n
\n\n Nov 04, 2009 8:03 AM EST
\n\n \n Capstone Therapeutics to Host Conference Call Discussing Third Quarter 2009 Operating Results - GlobeNewswire\n \n \n
\n\n Oct 22, 2009 4:52 PM EDT
\n\n \n Capstone Therapeutics to Present at 4th Annual BIOCOM Investor Conference - GlobeNewswire\n \n \n
\n\n Oct 13, 2009 3:35 PM EDT
\n\n \n Capstone Therapeutics Announces Presentation of Chrysalin(R) (TP508) Pre-Clinical Data At the American College of Surgeons 95th Annual Clinical Conference Demonstrating Significant Benefit in a Model of Acute Heart Disease and Elevated Cholesterol - GlobeNewswire\n \n \n
\n\n Sep 30, 2009 8:01 AM EDT
\n\n \n Capstone Therapeutics Announces Completion of Enrollment for Second of Two AZX100 Phase 2 Studies in Keloid Scarring; Phase 2 Study in Shoulder Surgery Scarring Reaches Enrollment Milestone - GlobeNewswire\n \n \n
\n\n Aug 12, 2009 6:00 AM EDT
\n\n \n Capstone Therapeutics Announces Second Quarter 2009 Financial Results - GlobeNewswire\n \n \n
\n
\n\n");